The Ninth Circuit Court of Appeals is set to hear arguments in August in a closely watched case about whether terminally ill patients have the right to use the psychedelic drug psilocybin under federal and state “right-to-try” laws, Law360 reported. The case, Advanced Integrative Medical Science Institute v. U.S. Drug …
Tag: reMind
New York lawmakers pass bill to make cannabis farmers markets permanent
New York legislators approved a bill that would allow marijuana farmers markets to become a regular part of the state’s legal cannabis landscape. The legislation, sponsored by Sen. Michelle Hinchey and Assemblymember Donna Lupardo, both Democrats, now heads to Gov. Kathy Hochul’s desk for consideration, Marijuana Moment reported. Under the …
Bright Green expands goals but still hasn’t harvested any DEA cannabis
Bright Green Corp. (Nasdaq: BGXX) recently published a letter from its chief executive officer, Gurvinder Singh, telling investors of its lofty goals and strategy of accepting foreign investor money through an EB-5 program, the employment-based fifth preference visa participants receive. According to the U.S. Citizenship and Immigration Services, an investor …
ICER report rebukes Lykos’ MDMA-AP study
The Institute for Clinical and Economic Review (ICER) recently posted its revised evidence report assessing the comparative clinical effectiveness and value of 3,4-Methylenedioxymethamphetamine-assisted psychotherapy (MDMA-AP, a psychotherapy protocol from Lykos Therapeutics) for the treatment of post-traumatic stress disorder (PTSD). ICER provides independent evaluations of medical tests, treatments, and systems. The …